The global Companion Diagnostic Technologies market was valued at US$ 2771.3 million in 2023 and is anticipated to reach US$ 6057.7 million by 2030, witnessing a CAGR of 11.3% during the forecast period 2024-2030.

Companion Diagnostic Technologies Market

Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Companion Diagnostic Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Diagnostic Technologies.

Report Scope

The Companion Diagnostic Technologies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Companion Diagnostic Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Companion Diagnostic Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Companion Diagnostic Technologies Market Report

Report Metric	Details
Report Name	Companion Diagnostic Technologies Market
Accounted market size in 2023	US$ 2771.3 million
Forecasted market size in 2030	US$ 6057.7 million
CAGR	11.3%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Immunohistochemistry Molecular Diagnostics
Segment by Application	Oncology Cardiovascular Central Nervous System Auto immune & Inflammation Virology Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Dako (Agilent Technologies), Qiagen, Roche, Abbott Laboratories, Thermo Fisher Scientific, bioMerieux, Myriad Genetics, Resonance Health Ltd., Leica Microsystems, Danaher
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Companion Diagnostic Technologies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Companion Diagnostic Technologies Market growing?

Ans: The Companion Diagnostic Technologies Market witnessing a CAGR of 11.3% during the forecast period 2024-2030.

What is the Companion Diagnostic Technologies Market size in 2030?

Ans: The Companion Diagnostic Technologies Market size in 2030 will be US$ 6057.7 million.

Who are the main players in the Companion Diagnostic Technologies Market report?

Ans: The main players in the Companion Diagnostic Technologies Market are Dako (Agilent Technologies), Qiagen, Roche, Abbott Laboratories, Thermo Fisher Scientific, bioMerieux, Myriad Genetics, Resonance Health Ltd., Leica Microsystems, Danaher

What are the Application segmentation covered in the Companion Diagnostic Technologies Market report?

Ans: The Applications covered in the Companion Diagnostic Technologies Market report are Oncology, Cardiovascular, Central Nervous System, Auto immune & Inflammation, Virology, Others

What are the Type segmentation covered in the Companion Diagnostic Technologies Market report?

Ans: The Types covered in the Companion Diagnostic Technologies Market report are Immunohistochemistry, Molecular Diagnostics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Companion Diagnostic Technologies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Immunohistochemistry

1.2.3 Molecular Diagnostics

1.3 Market by Application

1.3.1 Global Companion Diagnostic Technologies Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Oncology

1.3.3 Cardiovascular

1.3.4 Central Nervous System

1.3.5 Auto immune & Inflammation

1.3.6 Virology

1.3.7 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Companion Diagnostic Technologies Market Perspective (2019-2030)

2.2 Companion Diagnostic Technologies Growth Trends by Region

2.2.1 Global Companion Diagnostic Technologies Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Companion Diagnostic Technologies Historic Market Size by Region (2019-2024)

2.2.3 Companion Diagnostic Technologies Forecasted Market Size by Region (2025-2030)

2.3 Companion Diagnostic Technologies Market Dynamics

2.3.1 Companion Diagnostic Technologies Industry Trends

2.3.2 Companion Diagnostic Technologies Market Drivers

2.3.3 Companion Diagnostic Technologies Market Challenges

2.3.4 Companion Diagnostic Technologies Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Companion Diagnostic Technologies Players by Revenue

3.1.1 Global Top Companion Diagnostic Technologies Players by Revenue (2019-2024)

3.1.2 Global Companion Diagnostic Technologies Revenue Market Share by Players (2019-2024)

3.2 Global Companion Diagnostic Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Companion Diagnostic Technologies Revenue

3.4 Global Companion Diagnostic Technologies Market Concentration Ratio

3.4.1 Global Companion Diagnostic Technologies Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Technologies Revenue in 2023

3.5 Companion Diagnostic Technologies Key Players Head office and Area Served

3.6 Key Players Companion Diagnostic Technologies Product Solution and Service

3.7 Date of Enter into Companion Diagnostic Technologies Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Companion Diagnostic Technologies Breakdown Data by Type

4.1 Global Companion Diagnostic Technologies Historic Market Size by Type (2019-2024)

4.2 Global Companion Diagnostic Technologies Forecasted Market Size by Type (2025-2030)

5 Companion Diagnostic Technologies Breakdown Data by Application

5.1 Global Companion Diagnostic Technologies Historic Market Size by Application (2019-2024)

5.2 Global Companion Diagnostic Technologies Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Companion Diagnostic Technologies Market Size (2019-2030)

6.2 North America Companion Diagnostic Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Companion Diagnostic Technologies Market Size by Country (2019-2024)

6.4 North America Companion Diagnostic Technologies Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Companion Diagnostic Technologies Market Size (2019-2030)

7.2 Europe Companion Diagnostic Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Companion Diagnostic Technologies Market Size by Country (2019-2024)

7.4 Europe Companion Diagnostic Technologies Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Companion Diagnostic Technologies Market Size (2019-2030)

8.2 Asia-Pacific Companion Diagnostic Technologies Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2019-2024)

8.4 Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Companion Diagnostic Technologies Market Size (2019-2030)

9.2 Latin America Companion Diagnostic Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Companion Diagnostic Technologies Market Size by Country (2019-2024)

9.4 Latin America Companion Diagnostic Technologies Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Companion Diagnostic Technologies Market Size (2019-2030)

10.2 Middle East & Africa Companion Diagnostic Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2019-2024)

10.4 Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Dako (Agilent Technologies)

11.1.1 Dako (Agilent Technologies) Company Detail

11.1.2 Dako (Agilent Technologies) Business Overview

11.1.3 Dako (Agilent Technologies) Companion Diagnostic Technologies Introduction

11.1.4 Dako (Agilent Technologies) Revenue in Companion Diagnostic Technologies Business (2019-2024)

11.1.5 Dako (Agilent Technologies) Recent Development

11.2 Qiagen

11.2.1 Qiagen Company Detail

11.2.2 Qiagen Business Overview

11.2.3 Qiagen Companion Diagnostic Technologies Introduction

11.2.4 Qiagen Revenue in Companion Diagnostic Technologies Business (2019-2024)

11.2.5 Qiagen Recent Development

11.3 Roche

11.3.1 Roche Company Detail

11.3.2 Roche Business Overview

11.3.3 Roche Companion Diagnostic Technologies Introduction

11.3.4 Roche Revenue in Companion Diagnostic Technologies Business (2019-2024)

11.3.5 Roche Recent Development

11.4 Abbott Laboratories

11.4.1 Abbott Laboratories Company Detail

11.4.2 Abbott Laboratories Business Overview

11.4.3 Abbott Laboratories Companion Diagnostic Technologies Introduction

11.4.4 Abbott Laboratories Revenue in Companion Diagnostic Technologies Business (2019-2024)

11.4.5 Abbott Laboratories Recent Development

11.5 Thermo Fisher Scientific

11.5.1 Thermo Fisher Scientific Company Detail

11.5.2 Thermo Fisher Scientific Business Overview

11.5.3 Thermo Fisher Scientific Companion Diagnostic Technologies Introduction

11.5.4 Thermo Fisher Scientific Revenue in Companion Diagnostic Technologies Business (2019-2024)

11.5.5 Thermo Fisher Scientific Recent Development

11.6 bioMerieux

11.6.1 bioMerieux Company Detail

11.6.2 bioMerieux Business Overview

11.6.3 bioMerieux Companion Diagnostic Technologies Introduction

11.6.4 bioMerieux Revenue in Companion Diagnostic Technologies Business (2019-2024)

11.6.5 bioMerieux Recent Development

11.7 Myriad Genetics

11.7.1 Myriad Genetics Company Detail

11.7.2 Myriad Genetics Business Overview

11.7.3 Myriad Genetics Companion Diagnostic Technologies Introduction

11.7.4 Myriad Genetics Revenue in Companion Diagnostic Technologies Business (2019-2024)

11.7.5 Myriad Genetics Recent Development

11.8 Resonance Health Ltd.

11.8.1 Resonance Health Ltd. Company Detail

11.8.2 Resonance Health Ltd. Business Overview

11.8.3 Resonance Health Ltd. Companion Diagnostic Technologies Introduction

11.8.4 Resonance Health Ltd. Revenue in Companion Diagnostic Technologies Business (2019-2024)

11.8.5 Resonance Health Ltd. Recent Development

11.9 Leica Microsystems

11.9.1 Leica Microsystems Company Detail

11.9.2 Leica Microsystems Business Overview

11.9.3 Leica Microsystems Companion Diagnostic Technologies Introduction

11.9.4 Leica Microsystems Revenue in Companion Diagnostic Technologies Business (2019-2024)

11.9.5 Leica Microsystems Recent Development

11.10 Danaher

11.10.1 Danaher Company Detail

11.10.2 Danaher Business Overview

11.10.3 Danaher Companion Diagnostic Technologies Introduction

11.10.4 Danaher Revenue in Companion Diagnostic Technologies Business (2019-2024)

11.10.5 Danaher Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Roche

Abbott Laboratories

Thermo Fisher Scientific

Biomerieux

Myriad Genetics

Resonance Health Ltd.

Leica Microsystems

Danaher

Agilent Technologies

Dako (Agilent Technologies)

Qiagen NV

List of Tables

Table 1. Global Companion Diagnostic Technologies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Immunohistochemistry

Table 3. Key Players of Molecular Diagnostics

Table 4. Global Companion Diagnostic Technologies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Companion Diagnostic Technologies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Companion Diagnostic Technologies Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Companion Diagnostic Technologies Market Share by Region (2019-2024)

Table 8. Global Companion Diagnostic Technologies Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Companion Diagnostic Technologies Market Share by Region (2025-2030)

Table 10. Companion Diagnostic Technologies Market Trends

Table 11. Companion Diagnostic Technologies Market Drivers

Table 12. Companion Diagnostic Technologies Market Challenges

Table 13. Companion Diagnostic Technologies Market Restraints

Table 14. Global Companion Diagnostic Technologies Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Companion Diagnostic Technologies Market Share by Players (2019-2024)

Table 16. Global Top Companion Diagnostic Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic Technologies as of 2023)

Table 17. Ranking of Global Top Companion Diagnostic Technologies Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Companion Diagnostic Technologies Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Companion Diagnostic Technologies Product Solution and Service

Table 21. Date of Enter into Companion Diagnostic Technologies Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Companion Diagnostic Technologies Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Companion Diagnostic Technologies Revenue Market Share by Type (2019-2024)

Table 25. Global Companion Diagnostic Technologies Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Companion Diagnostic Technologies Revenue Market Share by Type (2025-2030)

Table 27. Global Companion Diagnostic Technologies Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Companion Diagnostic Technologies Revenue Market Share by Application (2019-2024)

Table 29. Global Companion Diagnostic Technologies Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Companion Diagnostic Technologies Revenue Market Share by Application (2025-2030)

Table 31. North America Companion Diagnostic Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Companion Diagnostic Technologies Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Companion Diagnostic Technologies Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Companion Diagnostic Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Companion Diagnostic Technologies Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Companion Diagnostic Technologies Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Companion Diagnostic Technologies Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Companion Diagnostic Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Companion Diagnostic Technologies Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Companion Diagnostic Technologies Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Companion Diagnostic Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2025-2030) & (US$ Million)

Table 46. Dako (Agilent Technologies) Company Detail

Table 47. Dako (Agilent Technologies) Business Overview

Table 48. Dako (Agilent Technologies) Companion Diagnostic Technologies Product

Table 49. Dako (Agilent Technologies) Revenue in Companion Diagnostic Technologies Business (2019-2024) & (US$ Million)

Table 50. Dako (Agilent Technologies) Recent Development

Table 51. Qiagen Company Detail

Table 52. Qiagen Business Overview

Table 53. Qiagen Companion Diagnostic Technologies Product

Table 54. Qiagen Revenue in Companion Diagnostic Technologies Business (2019-2024) & (US$ Million)

Table 55. Qiagen Recent Development

Table 56. Roche Company Detail

Table 57. Roche Business Overview

Table 58. Roche Companion Diagnostic Technologies Product

Table 59. Roche Revenue in Companion Diagnostic Technologies Business (2019-2024) & (US$ Million)

Table 60. Roche Recent Development

Table 61. Abbott Laboratories Company Detail

Table 62. Abbott Laboratories Business Overview

Table 63. Abbott Laboratories Companion Diagnostic Technologies Product

Table 64. Abbott Laboratories Revenue in Companion Diagnostic Technologies Business (2019-2024) & (US$ Million)

Table 65. Abbott Laboratories Recent Development

Table 66. Thermo Fisher Scientific Company Detail

Table 67. Thermo Fisher Scientific Business Overview

Table 68. Thermo Fisher Scientific Companion Diagnostic Technologies Product

Table 69. Thermo Fisher Scientific Revenue in Companion Diagnostic Technologies Business (2019-2024) & (US$ Million)

Table 70. Thermo Fisher Scientific Recent Development

Table 71. bioMerieux Company Detail

Table 72. bioMerieux Business Overview

Table 73. bioMerieux Companion Diagnostic Technologies Product

Table 74. bioMerieux Revenue in Companion Diagnostic Technologies Business (2019-2024) & (US$ Million)

Table 75. bioMerieux Recent Development

Table 76. Myriad Genetics Company Detail

Table 77. Myriad Genetics Business Overview

Table 78. Myriad Genetics Companion Diagnostic Technologies Product

Table 79. Myriad Genetics Revenue in Companion Diagnostic Technologies Business (2019-2024) & (US$ Million)

Table 80. Myriad Genetics Recent Development

Table 81. Resonance Health Ltd. Company Detail

Table 82. Resonance Health Ltd. Business Overview

Table 83. Resonance Health Ltd. Companion Diagnostic Technologies Product

Table 84. Resonance Health Ltd. Revenue in Companion Diagnostic Technologies Business (2019-2024) & (US$ Million)

Table 85. Resonance Health Ltd. Recent Development

Table 86. Leica Microsystems Company Detail

Table 87. Leica Microsystems Business Overview

Table 88. Leica Microsystems Companion Diagnostic Technologies Product

Table 89. Leica Microsystems Revenue in Companion Diagnostic Technologies Business (2019-2024) & (US$ Million)

Table 90. Leica Microsystems Recent Development

Table 91. Danaher Company Detail

Table 92. Danaher Business Overview

Table 93. Danaher Companion Diagnostic Technologies Product

Table 94. Danaher Revenue in Companion Diagnostic Technologies Business (2019-2024) & (US$ Million)

Table 95. Danaher Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Companion Diagnostic Technologies Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Companion Diagnostic Technologies Market Share by Type: 2023 VS 2030

Figure 3. Immunohistochemistry Features

Figure 4. Molecular Diagnostics Features

Figure 5. Global Companion Diagnostic Technologies Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Companion Diagnostic Technologies Market Share by Application: 2023 VS 2030

Figure 7. Oncology Case Studies

Figure 8. Cardiovascular Case Studies

Figure 9. Central Nervous System Case Studies

Figure 10. Auto immune & Inflammation Case Studies

Figure 11. Virology Case Studies

Figure 12. Others Case Studies

Figure 13. Companion Diagnostic Technologies Report Years Considered

Figure 14. Global Companion Diagnostic Technologies Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Companion Diagnostic Technologies Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Companion Diagnostic Technologies Market Share by Region: 2023 VS 2030

Figure 17. Global Companion Diagnostic Technologies Market Share by Players in 2023

Figure 18. Global Top Companion Diagnostic Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic Technologies as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Companion Diagnostic Technologies Revenue in 2023

Figure 20. North America Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Companion Diagnostic Technologies Market Share by Country (2019-2030)

Figure 22. United States Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Companion Diagnostic Technologies Market Share by Country (2019-2030)

Figure 26. Germany Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Companion Diagnostic Technologies Market Share by Region (2019-2030)

Figure 34. China Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Companion Diagnostic Technologies Market Share by Country (2019-2030)

Figure 42. Mexico Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Companion Diagnostic Technologies Market Share by Country (2019-2030)

Figure 46. Turkey Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Dako (Agilent Technologies) Revenue Growth Rate in Companion Diagnostic Technologies Business (2019-2024)

Figure 49. Qiagen Revenue Growth Rate in Companion Diagnostic Technologies Business (2019-2024)

Figure 50. Roche Revenue Growth Rate in Companion Diagnostic Technologies Business (2019-2024)

Figure 51. Abbott Laboratories Revenue Growth Rate in Companion Diagnostic Technologies Business (2019-2024)

Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Companion Diagnostic Technologies Business (2019-2024)

Figure 53. bioMerieux Revenue Growth Rate in Companion Diagnostic Technologies Business (2019-2024)

Figure 54. Myriad Genetics Revenue Growth Rate in Companion Diagnostic Technologies Business (2019-2024)

Figure 55. Resonance Health Ltd. Revenue Growth Rate in Companion Diagnostic Technologies Business (2019-2024)

Figure 56. Leica Microsystems Revenue Growth Rate in Companion Diagnostic Technologies Business (2019-2024)

Figure 57. Danaher Revenue Growth Rate in Companion Diagnostic Technologies Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions